Stem cell therapy means treating a disease or injury with stem cells, or with products made from them. Stem cells can renew themselves and can develop into more specialized cell types. The approved uses are narrow. Blood-forming stem cell transplantation is the best-established example, and most other stem cell treatments sold to patients remain unproven. This page explains the basic biology, the main types and sources, and how to read the evidence.
What makes a stem cell a stem cell
A stem cell has two defining abilities. It can self-renew, meaning it divides to produce more stem cells. It can also differentiate, meaning it can become a more specialized cell, such as a blood cell, cartilage cell or nerve cell. Most cells in an adult body have already taken on a fixed role. Stem cells keep the ability to make new specialized cells when the body needs to repair or replace tissue.
Stem cells are often described by how many cell types they can produce. Embryonic stem cells and induced pluripotent stem cells (iPS cells) are pluripotent, meaning they can form almost any cell type in the body. Adult or tissue-specific stem cells have a narrower range. Blood-forming stem cells, for example, produce the different types of blood cells, and mesenchymal stem cells can form bone, cartilage and fat cells under laboratory conditions.
The main types
Embryonic stem cells (ES cells) come from early embryos. They are pluripotent, but using them raises ethical questions and they are subject to strict rules in most countries.

Induced pluripotent stem cells (iPS cells) are made by reprogramming adult cells, such as skin cells, back to a stem-cell-like state. Shinya Yamanaka's group first reported them in mouse cells in 2006. Our page What Are iPS Cells? covers the discovery and the approved products in more detail.
Adult or tissue-specific stem cells are found in tissues such as bone marrow, fat and umbilical cord. Their range is narrower than ES or iPS cells, but they are easier to obtain. Blood-forming stem cells and mesenchymal stem cells are both in this group.
Where stem cells come from in clinical use
Bone marrow, fat tissue and umbilical cord tissue are the sources most often named for mesenchymal stem cells. Fat tissue is a common source for clinics that use a patient's own cells. Umbilical cord tissue yields cells from a donor, not from the patient. The source matters for two reasons: it affects how easily cells can be collected, and it determines whether the cells come from the patient or a donor. Donor-derived cells raise immune-compatibility and long-term safety questions that a patient's own cells do not.
What the evidence shows
The International Society for Stem Cell Research (ISSCR), a leading scientific society, states that very few stem cell treatments have been proven safe and effective, and that the list of diseases shown to benefit is still very short. The best-defined and most widely used stem cell treatment is hematopoietic stem cell transplantation, which is bone marrow transplantation for certain blood and immune disorders and for rebuilding the blood system after some cancer treatments. Some bone, skin and corneal injuries can be treated by grafting or implanting tissue.

The ISSCR also warns that a treatment's effect depends on the disease. Stem cells specific to one tissue usually cannot make cells for another tissue without careful laboratory work, so one stem cell treatment is unlikely to work across many conditions.
Research is active in many areas, including type 1 diabetes, traumatic spinal cord injury, aplastic anemia and corneal limbal stem cell deficiency. According to the Japan Science and Technology Agency, these projects are at the trial or clinical research stage. A trial result is not the same as an approved treatment.
Terms you will see in clinic materials
- Autologous means the cells came from the patient. The ISSCR notes that a patient's own cells are not automatically safe, because how the cells are collected, grown and returned matters.
- Allogeneic means the cells came from a donor. In Japan, treatments that use donor cells fall under the highest-risk class of the Act.
- Mesenchymal describes a family of adult stem cells, usually from bone marrow, fat or umbilical cord, with a narrower range of cell types than ES or iPS cells.
- Experimental does not mean a treatment is part of a clinical trial. The ISSCR states that an experimental treatment offered for sale is not the same as a clinical trial, and that responsibly conducted trials are how new treatments are established.
How to read a stem cell claim
Several warning signs appear repeatedly in marketing for unproven treatments:
- Broad promises. A single cell product said to treat many unrelated conditions, or to reverse aging, is a warning sign.
- Testimonials in place of data. Patient stories are not evidence of effect.
- Experimental wording. Calling a treatment "experimental" does not mean it is part of a clinical trial.
- Own-cell safety claims. Using a patient's own cells does not make a treatment automatically safe, because the way cells are collected, grown and returned matters.
The US Food and Drug Administration (FDA) says it has received reports of blindness, tumor formation and infections linked to unapproved regenerative medicine products. Its consumer page says the only approved stem cell products are blood-forming cells from umbilical cord blood. For how Japan regulates this kind of treatment, see how Japan regulates regenerative medicine.
Questions to ask before any stem cell treatment
- Which cell type is used, and where did the cells come from?
- Is the treatment approved for my condition, or is it offered under a trial or under a filed plan?
- What human studies support the claimed effect, and how was the effect measured?
- What are the known risks, and what happens if a complication occurs?
- Who is responsible for follow-up after I go home?

If you are considering a treatment in Japan, send the clinic's name and the treatment name to our advisors. We will check whether the clinic has filed a provision plan for that treatment. For a structured first step, see our pre-screening page.
Frequently asked questions
What is stem cell therapy in one sentence?
Stem cell therapy uses stem cells, or products made from them, to treat disease, and only a few uses have been proven safe and effective so far.
What is the difference between a stem cell and an ordinary cell?
An ordinary cell in an adult body has already taken on a fixed role. A stem cell can renew itself and can develop into more specialized cell types.
Are embryonic and iPS cells the same?
They are similar in range, since both are pluripotent. Embryonic stem cells come from early embryos. iPS cells are made by reprogramming adult cells, so no embryo is needed.
Can stem cells turn into any cell in the body?
Only pluripotent stem cells, such as ES and iPS cells, have that broad range. Adult stem cells, including blood-forming and mesenchymal stem cells, have a narrower range.
Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.
Sources: International Society for Stem Cell Research (ISSCR), "Nine Things to Know About Stem Cell Treatments" (aboutstemcells.org); US Food and Drug Administration, Important Patient and Consumer Information About Regenerative Medicine Therapies; Takahashi and Yamanaka, Cell 2006 (PubMed 16904174); Nobel Prize, 2012 Prize in Physiology or Medicine summary; Japan Science and Technology Agency (JST) Science Portal, 18 March 2026. Checked November 2026; the relevant society or regulator's publications prevail.
Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.